4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000107
Chairperson & CEO sold 9,500 shares at an average $530.42 ($5,038,971)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-27 | Sale : show line 2 in the form 10b5-1 | −680 | $525.81 | $357,552 | 333,263 | I |
| 2026-07-27 | Sale : show line 3 in the form 10b5-1 | −890 | $527.14 | $469,152 | 332,373 | I |
| 2026-07-27 | Sale : show line 4 in the form 10b5-1 | −650 | $528.51 | $343,530 | 331,723 | I |
| 2026-07-27 | Sale : show line 5 in the form 10b5-1 | −1,797 | $529.75 | $951,959 | 329,926 | I |
| 2026-07-27 | Sale : show line 6 in the form 10b5-1 | −1,121 | $530.49 | $594,675 | 328,805 | I |
| 2026-07-27 | Sale : show line 7 in the form 10b5-1 | −1,836 | $531.65 | $976,107 | 326,969 | I |
| 2026-07-27 | Sale : show line 8 in the form 10b5-1 | −1,529 | $532.38 | $814,004 | 325,440 | I |
| 2026-07-27 | Sale : show line 9 in the form 10b5-1 | −957 | $533.53 | $510,590 | 324,483 | I |
| 2026-07-27 | Sale : show line 10 in the form 10b5-1 | −40 | $535.04 | $21,402 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $530.42 · $5,038,971 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-27 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option | −9,500 | 265,410 | I |
Loading xslF345X06/primarydocument.xml…